Split- and Reduced-Dose Imatinib in Chronic Myeloid Leukemia: Case Report.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2024, v. 14, n. 3, p. 121
- By:
- Publication type:
- Article
Works matching IS 21641153 AND DT 2024 AND VI 14 AND IP 3
Results: 5
1
2
Evaluation of Pharmacist-Driven Approach to Monitoring for Neutropenia Related to CDK4/6 Inhibitors in Women With Advanced Breast Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2024, v. 14, n. 3, p. 115
- By:
- Publication type:
- Article
3
Addition of Venetoclax to Intensive Induction Regimens for AML Does Not Increase Rates of Febrile Neutropenia.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2024, v. 14, n. 3, p. 103
- By:
- Publication type:
- Article
4
Evaluation of Acute Irinotecan-Related AEs at 2 Different Infusion Rates in Patients With Gastrointestinal Malignancies.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2024, v. 14, n. 3, p. 97
- By:
- Publication type:
- Article
5
Comparison of Adverse Events Between 2 Pembrolizumab Monotherapy Dosing Regimens.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2024, v. 14, n. 3, p. 108
- By:
- Publication type:
- Article